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MicroRNAs (miRNAs) are short, noncoding RNAs that
post-transcriptionally regulate gene expression. While
hundreds of mammalian miRNA genes have been iden-
tified, little is known about the pathways that regulate
the production of active miRNA species. Here we show
that a large fraction of miRNA genes are regulated post-
transcriptionally. During early mouse development,
many miRNA primary transcripts, including the Let-7
family, are present at high levels but are not processed by
the enzyme Drosha. An analysis of gene expression in
primary tumors indicates that the widespread down-
regulation of miRNAs observed in cancer is due to a
failure at the Drosha processing step. These data uncover
a novel regulatory step in miRNA function and provide a
mechanism for miRNA down-regulation in cancer.
Supplemental material is available at http://www.genesdev.org.
Received April 27, 2006; revised version accepted June 14,
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The founding microRNA (miRNA), lin-4, was discovered
more than 20 years ago in the nematode Caenorhabditis
elegans (Lee et al. 1993). Elegant studies demonstrated
that the gene product of lin-4 was a noncoding RNA that
post-transcriptionally regulated several critical genes
during development (Wightman et al. 1993). More re-
cently, a large number of miRNA genes have been iden-
tified in plant and animal genomes. To date, >300
miRNAs have been validated in the human genome, and
computational predictions suggest that many hundreds
more exist (Aravin and Tuschl 2005). While it is clear
that these small, noncoding RNAs have essential func-
tions in mammalian biology, few miRNA genes have
been functionally linked to specific cellular pathways.
For example, miR-181 modulates hematopoietic differ-
entiation, and miR-1 and miR-133 participate in skeletal
and cardiac muscle development. The polycistronic clus-
ter miR-17∼92 promotes lymphomagenesis, while Let-7
suppresses proliferation by targeting the oncogene Ras
(for review, see Wienholds and Plasterk 2005).
For most miRNA genes, however, biological informa-
tion is limited to expression analyses. In mouse and ze-
brafish, few miRNAs are expressed in early embryos
(Thomson et al. 2004; Wienholds et al. 2005). During
mid- to late embryonic development, large numbers of
miRNAs are induced in temporal and spatial patterns
(Kloosterman et al. 2006). This culminates in adult tis-
sues, where a large fraction of the known miRNA genes
are expressed. Interestingly, most of these same miRNA
genes are down-regulated in cancer, perhaps reflecting a
loss of cellular differentiation (Takamizawa et al. 2004;
Lu et al. 2005). The regulatory mechanism behind these
expression changes is largely unknown, although the
most obvious candidate is transcriptional control. It is
difficult, however, to reconcile this model with the
widespread, parallel reduction in miRNA expression ob-
served in most types of human cancer.
A second possibility is that miRNA maturation is a
regulated event. The biogenesis of miRNAs begins with
a primary transcript, termed the pri-miRNA, which is
generated by RNA polymerase II (for review, see Kim
2005). The active species is contained in a stem–loop
structure that is liberated by the nuclear ribonuclease III
(RNase III) Drosha. This stem–loop, termed the pre-
miRNA or precursor, is exported from the nucleus in a
Ran/GTP/Exportin 5-mediated event. In the cytoplasm,
the precursor is further processed by the RNase III en-
zyme Dicer to generate the mature miRNA species. In a
concerted reaction, this siRNA-like product is loaded
into the RNA induced silencing complex (RISC), where
it mediates target mRNA translational suppression (Du
and Zamore 2005; Gregory et al. 2005; Maniataki and
Mourelatos 2005).
In principle, any step during this maturation process
could be regulated. The core enzymes are widely ex-
pressed, however, and no post-translational regulation of
Drosha or Dicer has been reported. Discrepancies be-
tween the levels of primary transcript, precursor, and
mature miRNA species have been reported; however, no
clear model is apparent (Suh et al. 2004; Eis et al. 2005).
Here we report that a large fraction of miRNAs is regu-
lated during the Drosha processing step, and this regula-
tion has a major impact on miRNA expression during
embryonic development and in cancer.
Results and Discussion
A striking event during mouse development is the mas-
sive induction of Let-7 family miRNAs at ∼10.5 d of
gestation. This is exemplified by Let-7g. This miRNA is
housed in the second intron of the WD-40 repeat gene
AK037620 (Fig. 1A). Processing of this primary transcript
by Drosha yields a 79-nt stem–loop precursor. Further
processing by Dicer leads to the 21-nt mature species.
We analyzed the expression of all three molecular forms
by Northern blotting (Fig. 1B). As previously reported,
mature Let-7g is undetectable in embryonic stem (ES)
cells and P19 embryonal teratocarcinoma cells (Thom-
son et al. 2004). Expression is detectable at 10.5 d gesta-
tion and is high at 14.5 d. The precursor is detectable
slightly earlier than the mature miRNA, suggesting a
delay at the Dicer processing step. Similar results have
[Keywords: miRNA; microRNA; let-7; RISC; Drosha; cancer]
5Corresponding author.
E-MAIL hammond@med.unc.edu; FAX (919) 966-1856.
Article published online ahead of print. Article and publication date are
online at http://www.genesdev.org/cgi/doi/10.1101/gad.1444406.
2202 GENES & DEVELOPMENT 20:2202–2207 © 2006 by Cold Spring Harbor Laboratory Press ISSN 0890-9369/06; www.genesdev.org
been observed in mouse and Drosophila development
(Hutvagner et al. 2001; Schulman et al. 2005). Surpris-
ingly, the primary transcript is highly expressed through-
out development, with little difference in expression be-
tween ES cells and 14.5-d embryos. This discrepancy is
not resolved by the amount of unspliced pri-miRNA,
since this is also essentially constant (Fig. 1C).
We next quantitated the levels of primary and mature
species by real-time RT-PCR. We adapted a published
procedure to measure the amount of both species from a
single RT reaction (see Supplemental Figs. 1, 2 for vali-
dation; Fig. 1D illustrates a nonquantitative example;
Shi and Chiang 2005). U6 snRNA was used for normal-
ization for mature and primary species. This RNA ex-
hibited more consistent expression during embryonic de-
velopment than more typical reference RNAs such as
-2 microglobulin, glyceraldehyde-3-phosphate dehydro-
genase, and -glucuronidase. Using this procedure, we
determined that the amount of mature Let-7g increases
4200-fold between ES cells and 14.5-d embryos. As ob-
served by Northern blot analysis, expression levels of the
primary transcript do not match the mature miRNA but
are relatively constant (Fig. 1E, note log scale).
There are several possible explanations for the differ-
ent expression levels of the pri-miRNA and the mature
miRNA. There could be rapid turnover of the mature
species in ES cells compared to late embryos. This is
unlikely, since mature miRNAs from other gene fami-
lies are present in ES cells (e.g., miR-290∼295), and pub-
lished data suggest that all miRNAs are loaded into RISC
complexes nondiscriminately (Liu et
al. 2004). A second possibility is that
the precursor for Let-7g is retained in
the nucleus or otherwise made inac-
cessible to Dicer. In that circum-
stance, we would expect to see an ac-
cumulation of precursor. Our data
disagree with this, since the precursor
is essentially undetectable in ES cells.
A third possibility, most congruous
with our data, is that processing of
Let-7g is blocked at the Drosha step.
Release of the block would enable
production of mature Let-7g. It is
worth emphasizing that this is not
simply a delay in processing during
development, but a complete block.
ES cells are grown continuously in
culture, express high levels of Let-7g
primary transcript, and never process
a significant quantity to the precursor
or mature species.
We next investigated processing of
other miRNA genes that are ex-
pressed during development (Fig. 2).
Let-7 family miRNAs are located at
eight genomic loci (Griffiths-Jones et
al. 2006). Of these we were able to
detect primary transcripts for four
loci. Notable is the Let-7f-2/miR-98
cistron, which is located within an in-
tron of the widely expressed ubiquitin
ligase gene HUWE-1. All four primary
transcripts were expressed at similar
levels throughout development. Simi-
lar to Let-7g, all mature miRNAs
within these genes were elevated several thousandfold
between ES cells and 14.5 d of gestation. The correlation
between primary transcript expression and mature
miRNA expression was close to zero, with the exception
of Let-7i (see Table 1). For this miRNA, the primary tran-
script is induced during development, although there is
still a large difference in processing efficiency (300-fold)
(Table 1). Two of the four Let-7 clusters we analyzed
were intronic, and two were exonic. Thus there is no
correlation between regulated processing by Drosha and
intron/exon location.
This Drosha regulatory step has not been observed in
other organisms. C. elegans let-7, for example, is induced
at the fourth larval stage and continues into the adult.
Expression is controlled by defined enhancer elements in
the promoter of the primary transcript (Johnson et al.
2003). Expression of the primary transcript is closely cor-
related with mature let-7 (Bracht et al. 2004).
The developmental function of Let-7 family members
in mammals is not known. There have been reports of
decreased Let-7 expression in primary tumors (Takam-
izawa et al. 2004; Lu et al. 2005). This may have func-
tional consequences. The oncogene Ras is a validated
target of Let-7 (Johnson et al. 2005). Thus, decreased
Let-7 expression would lead to increased Ras expression,
which would promote survival of tumor cells. Our data
raise the possibility that Let-7 down-regulation in tu-
mors is post-transcriptional (see below).
Several other families of miRNAs are up-regulated
during mouse development. We were able to detect pri-
Figure 1. Expression of let-7g during mouse development. (A) The genomic organization of
Let-7g is shown. RT-PCR primer sites are indicated by arrows. Primers Ex1 and Ex2 were used
for PCR of the primary transcript. Primers Ex1 and In1 were used for PCR of the unspliced
primary transcript. (B) Northern blot analysis of the molecular species of Let-7g. 18S rRNA and
U6 snRNA were used for loading controls for pri-miRNA and pre-miRNA/mature, respec-
tively. (C) Nonquantitative RT-PCR of the unspliced primary transcript. Control reactions
without the reverse transcription step are shown. (D) Nonquantitative RT-PCR of the let-7g
primary transcript and mature species. The U6-snRNA reference is also shown. The right lanes
are control reactions without reverse transcription step. (E) Real-time RT-PCR analysis of the
let-7g primary transcript and mature species. Reactions were performed in triplicate and nor-
malized to U6 cycle threshold values. Expression is shown as relative values on a logarithmic
scale.
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mary transcripts for nine of these miRNAs. Most cases
exhibited regulated Drosha processing (Fig. 2; Table 1).
Exceptions were miR-21 and the miR-143/miR-145 clus-
ter. Both primary transcripts matched expression of the
mature species (correlation = 1.0 and 0.99, respectively).
Another interesting example is the miR-15/miR-16 cis-
tron, which is located at two genomic loci. Each primary
transcript displays distinct expression kinetics. The
Chromosome 14 copy is located within an uncharacter-
ized gene that is induced during development. The Chro-
mosome 3 copy, in contrast, is located within the con-
densin subunit SMC4L1, which is constitutively ex-
pressed. Thus, each pri-miRNA contributes to the
mature species in a complex manner, with a post-tran-
scriptionally regulated component (Chromosome 3) and
a transcriptionally regulated component (Chromosome
14).
It should be noted that coordinate expression of the
primary transcript and the mature miRNA does not
prove that Drosha processing is not regulated. Such
miRNAs (Table 1, bottom panel) may be regulated at
transcription and Drosha processing. It remains a possi-
bility that all miRNAs are regulated at the Drosha step,
except for miRNAs that have demonstrated expression
in the early mouse embryo. Interestingly, this has impli-
cations for experiments that use ectopic expression of
miRNAs in ES cells. We predict that this would fail to
produce the mature species, unless cis-regulatory ele-
ments were removed from the expression cassette.
Our data suggest that the differentiation events that
occur during embryonic development activate Drosha
processing of specific miRNAs. To directly test this we
used the teratocarcinoma cell line P19, which can be
differentiated in culture into multiple cell types (Rud-
nicki et al. 1990). miRNA microarray expression analy-
sis of untreated and differentiated P19 cells mirrors the
expression changes observed during mouse development
(data not shown). Embryonic miRNAs, such as the
miR-290∼295 cluster, are down-regulated during differ-
entiation. In contrast, miRNAs that are up-regulated
during mouse development, including Let-7 family
members, are increased upon differentiation. As in em-
bryonic development, the increases in Let-7 miRNAs are
not coupled to transcription of the pri-miRNA (see Fig. 3).
Figure 3. miRNA expression during P19 cell differentiation. P19
teratocarcinoma cells were differentiated by forming embryoid bod-
ies for 4 d in the presence of all-trans retinoic acid (RA), followed by
plating without RA. Arrows indicate RA treatment and plating
time. Primary transcript and mature miRNA species were quanti-
tated by real-time RT-PCR. Reactions were performed in triplicate
and normalized to U6 cycle threshold values. Expression is shown as
relative values on a linear scale. Red bars indicate mature miRNA,
and blue bars indicate pri-miRNA.




















Pearson correlations were calculated for each mature miRNA/
pri-miRNA pair and are shown in the middle column. The
change in processing efficiency is defined as the ratio of mature
to pri-miRNA in a 14.5-d embryo divided by the ratio of mature
to pri-miRNA in ES cells, and is shown in the right column. The
table is divided into miRNAs regulated by Drosha (top) and
miRNAs potentially unregulated by Drosha (bottom).
Figure 2. miRNA expression during mouse development. The ex-
pression levels of primary transcript and mature species from 12
representative miRNAs are shown. Red bars represent mature
miRNA, and blue bars represent primary transcript. All analyses are
performed with the following RNA samples, from left to right: P19
teratocarcinoma cell line; embryonic stem cell line; 10.5-d gestation
mouse embryo; 14.5-d gestation mouse embryo. Reactions were per-
formed in triplicate and normalized to U6 cycle threshold values.
Expression is shown as relative values on a logarithmic scale. The
bold font indicates the mature miRNA gene that was used for RT-
PCR analysis. In all cases, these are unique miRNA sequences in the
mouse genome.
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One experimental observation of cancer cells is the
widespread alterations in miRNA expression. While
some miRNAs are elevated, for example, the oncogenic
cluster miR-17∼92, most miRNAs have significantly re-
duced expression (He et al. 2005; Lu et al. 2005). Our data
raise the possibility that these reductions are a conse-
quence of the Drosha processing block. To address this,
we analyzed existing expression data, comparing mature
miRNA levels with the primary transcript. The most
complete data set, from the Broad Institute, has Af-
fymetrix mRNA expression data and Luminex miRNA
data from a wide range of primary tumors and normal
tissues (Ramaswamy et al. 2001; Lu et al. 2005). We com-
bined the data set in the following manner: 68 tumors
and 21 normal tissue samples had data for miRNA and
mRNA expression. Of 217 miRNAs, 22 could be mapped
to a primary transcript that was present on the Af-
fymetrix microarray. When this restricted miRNA data
set was hierarchically clustered, the normal samples
were located in a single node with some tumor samples,
while most tumors clustered in a
separate node (Fig. 4A). The tumor
samples had overall reduction in
miRNA expression levels. This was
qualitatively similar to the entire
miRNA expression map, as previ-
ously published (Lu et al. 2005).
We then created an expression map
of primary transcript expression lev-
els (Fig. 4A). The samples and genes
are arranged in the same order as for
the miRNA expression map. The high
and low clusters of expression are
completely lost in the primary tran-
script expression map. We performed
correlation analysis between each
mature/pri-miRNA expression pair,
for each sample. The data are repre-
sented in the histogram in Figure 4B.
There is no correlation between pri-
miRNA and mature expression in the
tumor samples, while the normal tis-
sue samples had positive correlation
(KS test, p < 0.01). This demonstrates
that the miRNA alterations that oc-
cur in tumors, for this limited set of
genes, are not due to misregulated
transcription.
Our data suggest a multistep model
for the control of miRNA expression.
Transcription of the pri-miRNA can
be regulated, as has been demon-
strated for tissue-specific miRNAs
(Fazi et al. 2005; O’Donnell et al.
2005; Zhao et al. 2005; Chen et al.
2006). Processing at the Dicer step
can be delayed or inhibited (Hutvag-
ner et al. 2001; Schulman et al. 2005;
Obernosterer et al. 2006). We demon-
strate that further suppression of
miRNA production is achieved at the
Drosha step. This may be necessary
for early development, where inap-
propriate expression of even small
amounts of Let-7 may promote differ-
entiation, with disastrous conse-
quences. This model also allows miRNAs to be located
in essential housekeeping genes that are ubiquitously
expressed.
The biochemical nature of Drosha regulation is un-
known. We measured the expression levels of Drosha
and its binding partner DGCR8, during the P19 differen-
tiation time course (Supplemental Fig. 3). No induction
occurred concordant with the production of mature
miRNAs. It is possible these proteins are regulated
by post-translational modification. Alternatively, addi-
tional regulatory binding proteins may be required for
specific miRNA processing. Recently, adensosine deami-
nase (ADAR) editing of specific pri-miRNAs has been
reported (Yang et al. 2006). This editing event leads to
decreased processing of the miRNA by Drosha and in-
creased turnover by the Tudor-SN nuclease. We tested
whether this mechanism is responsible for the Drosha
block during embryogenesis. We failed to find evidence
of A-I editing of Let-7 pri-miRNAs in ES cells (data not
shown). Our data do not, however, discount the possibil-
Figure 4. miRNA expression in primary tumors. (A) Normalized miRNA expression data
from Lu et al. (2005) were clustered hierarchically in both dimensions and are displayed as an
expression map. Yellow indicates increased expression, and blue indicates decreased expres-
sion, relative to the median. Primary transcript expression data from Ramaswamy et al. (2001)
were mapped in the same order as the mature miRNA expression map. Mature miRNA/
primary transcript gene pairs are indicated on the right. Tumor samples are indicated in red,
and normal tissues are indicated in black. (B) Pearson correlation values for each mature/pri-
miRNA value pair were calculated. Values for normal samples (dashed line) and tumor
samples (solid line) are plotted as a histogram.
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ity of other structural changes in the pri-miRNA that
block processing. An alternative mechanism is the se-
questration of regulated pri-miRNAs away from the pro-
cessing apparatus. The exact nature of the regulatory
mechanism awaits further investigation.
Materials and methods
Cell lines
The feederless ES cell line E14Tg2A.4 was grown on gelatin-coated plates
in Glasgow MEM (Sigma) supplemented with 2 mM glutamine, 1 mM
pyruvate, 1× nonessential amino acids, 15% fetal bovine serum (Hy-
clone), 0.1 mM -mercaptoethanol, and 103 units/mL leukocyte inhibi-
tory factor (Chemicon). The P19 teratocarcinoma cell line was grown in
DMEM (Sigma) supplemented with 7.5% calf serum (Hyclone) and 2.5%
fetal bovine serum. P19 cells were differentiated as follows: Cells were
seeded on nonadhesive plates in -MEM (Sigma) supplemented with 5%
fetal bovine serum and 500 nM all-trans retinoic acid (Sigma). After 4 d,
the aggregated cells were plated on standard tissue culture dishes in
DMEM supplemented with 7.5% calf serum and 2.5% fetal bovine se-
rum, and grown for the indicated number of days.
RNA isolation
Dissected whole embryos from pregnant CD1 mice were flash-frozen in
liquid nitrogen and pulverized into powder. Total RNA was extracted
from pooled embryos of two to eight embryos or from cell lines with
Trizol Reagent (Invitrogen) according to the manufacturer’s instructions.
Northern blot analysis of mRNA
Five micrograms of total RNA was resolved on a 1% agarose formalde-
hyde gel and transferred overnight to a positively charged nylon mem-
brane by capillary transfer with 10× SSC. The membrane was washed
briefly in 2× SSC, dried, and UV cross-linked, and incubated overnight
with 107 cpm of a random-primed probe directed against the mouse Let-
7g primary transcript in Church and Gilbert high-stringency buffer. PCR
primers specific for the mouse Let-7g primary transcript (let-7g-probe-F,
5-TTTAGTCCCAATGGCGAGAC-3; let-7g-probe-R, 5-CATCACCA
CACCCTTGAATG-3) were used to make the probe. The membrane
was washed once for 15 min at 42°C in 2× SSC, 0.1% SDS and then twice
for 15 min at 65°C in 0.2× SSC, 0.1% SDS. PhosphorImaging using the
Storm system (Molecular Dynamics) revealed the Let-7g primary tran-
script. The size of pri-Let-7g (3.7 kb) was confirmed against 18S and 28S
rRNA markers. The size of pre-Let-7g was confirmed against an in vitro
transcribed pre-Let-7g RNA. All primers were purchased from MWG
Biotech.
Northern blot analysis of pre-miRNA and mature miRNA
Five micrograms of total RNA was resolved on 15% (mature) or 7.5%
(precursor) acrylamide–8 M urea–TAE gels as described previously (Ham-
mond et al. 2000). After electroblotting to Hybond N+ membranes, blots
were probed with an end-labeled Locked Nucleic Acid (LNA) probe AC
TgTaCaAaCtAcTaCcTcA (small letters are LNA; caps are DNA). Hybrid-
ization was performed in Church and Gilbert high-stringency buffer at
65°C, followed by three washes in 0.1× SSC at 65°C.
Quantitative RT-PCR
Total RNA (20 µg) was DNase I (Promega) treated according to the manu-
facturer’s instructions, phenol:chloroform extracted, ethanol precipi-
tated, and dissolved in DEPC-treated dH2O. RNA (10 µg) was polyade-
nylated using Poly(A) polymerase (Ambion) according to the manufac-
turer’s instructions, phenol:chloroform extracted, ethanol-precipitated,
and dissolved in DEPC-treated dH2O. A modified cDNA was made as
follows: 10 µg of polyadenylated RNA was reverse-transcribed using
Superscript II reverse transcriptase (Invitrogen) with 2.5 µg of random
hexamers and 500 ng of oligo(dT) adapter primer (5-GCGAGCACAG
AATTAATACGACTCACTATAGGTTTTTTTTTTTTVN-3) according
to the manufacturer’s instructions. The reaction was terminated by in-
cubation at 70°C for 10 min and diluted into 2 mL of dH2O (5 µg/mL).
Quantitative PCR was used to measure both the mature miRNA and the
host mRNA transcript as follows: 5 µL of cDNA was mixed with 5 pmol
of both the forward and reverse primers in a final volume of 12.5 µL and
mixed with 12.5 µL of 2× SYBR Green PCR master mix (Applied Biosys-
tems). Primer sequences and other pri-miRNA information are in Supple-
mental Table 1. All reactions were run in triplicate on a DNA Engine
Opticon 2 (MJ Research) using two amplification protocols. A standard
protocol was performed for the pri-miRNA PCR, 20 sec at 94°C, 30 sec at
59°C, and 20 sec at 72°C for 40 cycles. Mature miRNA PCR was per-
formed according to the high-stringency protocol of Shi and Chiang
(2005) except the reverse primer Mir-qPCR-3-3 (5-GCGAGCA
CAGAATTAATACGACTCAC-3) was used in conjunction with an ex-
act sequence-specific primer to each miRNA. Mature and pri-miRNA
expression both used the reference gene U6 snRNA (U6-F, 5-CGCTTC
GGCAGCACATATAC-3; U6-R, 5-TTCACGAATTTGCGTGTCAT-
3). Expression was calculated using the formula 2− CTwith CT = (CT
miRNA − CT reference RNA) for mature miRNA or CT = (CT pri-
miRNA − CT reference RNA) for pri-miRNA. Nonquantitative PCR con-
ditions for the Let-7g pri-miRNA and mature miRNA, and U6 reference
gene were as mentioned above, except the cycle numbers were 40, 35,
and 30, respectively. The same conditions were performed on an equal
amount of DNase I-treated RNA as a negative control. Reactions (5 µL)
were resolved by electrophoresis on 12% native polyacrylamide TBE gels
and stained with ethidium bromide. Unspliced pri-miRNA was analyzed
by RT-PCR at 50 cycles. The same conditions were performed on an
equal amount of DNase I-treated RNA as a negative control. For analysis
of Drosha, DGCR-8, and Oct-4, qRT-PCR was performed similarly, using
b2-macroglobulin as a reference RNA.
Microarray gene expression analysis
Normalized, log-transformed expression data were downloaded from
http://www.broad.mit.edu/cgi-bin/cancer/datasets.cgi. Eighty-nine samples
were common to the miRNA and mRNA data sets. Twenty-two miRNA/
pri-miRNA pairs were found in the combined data sets. This reduced set
of miRNA data was median-centered by gene and hierarchically clus-
tered in both dimensions using Cluster software (Stanford University).
An expression map was generated using Treeview software (Stanford
University). The pri-miRNA data set was arranged in the same order as
the miRNA clustered data and median-centered by gene, and a nonclus-
tered expression map was generated. The Pearson correlation of normal-
ized, log-transformed intensities was calculated for each mature/pri-
miRNA pair. Pairwise correlations were tabulated across tumor or nor-
mal samples, and a smoothed histogram was generated.
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